ELCC-话题@MedSci

#ELCC#

16篇内容 | 1017人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2193592, encodeId=2ef9219359210, content=<a href='/topic/show?id=384b8220449' target=_blank style='color:#2F92EE;'>#肺癌#</a> <a href='/topic/show?id=356b112349dd' target=_blank style='color:#2F92EE;'>#欧洲肺癌大会#</a> <a href='/topic/show?id=ac3066568c' target=_blank style='color:#2F92EE;'>#ELCC#</a>, objectTitle=国际会议 | 2024 ELCC：肺癌重点研究摘要速览！, objectType=article, longId=816160, objectId=be1f816160da, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/conference-with-doctors-in-medical-aprons-PT29AAG.jpg, objectUrl=/article/show_article.do?id=be1f816160da, replyNumber=0, likeNumber=92, createdTime=2024-03-16, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=be1f816160da, moduleTitle=国际会议 | 2024 ELCC：肺癌重点研究摘要速览！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=be1f816160da)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2034123, encodeId=170c203412368, content=<a href='/topic/show?id=ac3066568c' target=_blank style='color:#2F92EE;'>#ELCC#</a>, objectTitle=ELCC 2022：创新药临床研究汇总, objectType=article, longId=302208, objectId=35f6302208c2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=35f6302208c2, replyNumber=0, likeNumber=107, createdTime=2022-09-18, rootId=0, userName=chendoc242, userId=8994206, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=35f6302208c2, moduleTitle=ELCC 2022：创新药临床研究汇总, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=35f6302208c2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2034138, encodeId=627f2034138c5, content=<a href='/topic/show?id=ac3066568c' target=_blank style='color:#2F92EE;'>#ELCC#</a>, objectTitle=ELCC 2022：创新药临床研究汇总, objectType=article, longId=302208, objectId=35f6302208c2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=35f6302208c2, replyNumber=0, likeNumber=112, createdTime=2022-06-06, rootId=0, userName=chendoc242, userId=8994206, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=35f6302208c2, moduleTitle=ELCC 2022：创新药临床研究汇总, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=35f6302208c2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2034122, encodeId=c188203412207, content=<a href='/topic/show?id=ac3066568c' target=_blank style='color:#2F92EE;'>#ELCC#</a>, objectTitle=【ELCC2018】PACIFIC全新数据：1年Durvalumab可推迟多项症状恶化时间, objectType=article, longId=135442, objectId=fe80135442f9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fe80135442f9, replyNumber=0, likeNumber=116, createdTime=2018-09-13, rootId=0, userName=chendoc242, userId=8994206, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fe80135442f9, moduleTitle=【ELCC2018】PACIFIC全新数据：1年Durvalumab可推迟多项症状恶化时间, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fe80135442f9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2034137, encodeId=b843203413ee2, content=<a href='/topic/show?id=ac3066568c' target=_blank style='color:#2F92EE;'>#ELCC#</a>, objectTitle=【ELCC2018】PACIFIC全新数据：1年Durvalumab可推迟多项症状恶化时间, objectType=article, longId=135442, objectId=fe80135442f9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fe80135442f9, replyNumber=0, likeNumber=91, createdTime=2019-01-25, rootId=0, userName=chendoc242, userId=8994206, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fe80135442f9, moduleTitle=【ELCC2018】PACIFIC全新数据：1年Durvalumab可推迟多项症状恶化时间, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fe80135442f9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2034121, encodeId=21652034121dd, content=<a href='/topic/show?id=ac3066568c' target=_blank style='color:#2F92EE;'>#ELCC#</a>, objectTitle=ELCC 2016：Tagrisso一线治疗EGFR T790M突变NSCLC患者，PFS长达19.3个月, objectType=article, longId=66570, objectId=3bc2665e07d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3bc2665e07d, replyNumber=0, likeNumber=99, createdTime=2016-09-05, rootId=0, userName=chendoc242, userId=8994206, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3bc2665e07d, moduleTitle=ELCC 2016：Tagrisso一线治疗EGFR T790M突变NSCLC患者，PFS长达19.3个月, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3bc2665e07d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2034136, encodeId=58a2203413626, content=<a href='/topic/show?id=ac3066568c' target=_blank style='color:#2F92EE;'>#ELCC#</a>, objectTitle=ELCC 2016：Tagrisso一线治疗EGFR T790M突变NSCLC患者，PFS长达19.3个月, objectType=article, longId=66570, objectId=3bc2665e07d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3bc2665e07d, replyNumber=0, likeNumber=110, createdTime=2017-03-02, rootId=0, userName=chendoc242, userId=8994206, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3bc2665e07d, moduleTitle=ELCC 2016：Tagrisso一线治疗EGFR T790M突变NSCLC患者，PFS长达19.3个月, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3bc2665e07d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2034120, encodeId=ef9e203412050, content=<a href='/topic/show?id=ac3066568c' target=_blank style='color:#2F92EE;'>#ELCC#</a>, objectTitle=ELCC2015：肺癌研究热点精粹, objectType=article, longId=49805, objectId=ccb0498054a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ccb0498054a, replyNumber=0, likeNumber=80, createdTime=2015-05-05, rootId=0, userName=chendoc242, userId=8994206, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ccb0498054a, moduleTitle=ELCC2015：肺癌研究热点精粹, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ccb0498054a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2034135, encodeId=97db203413561, content=<a href='/topic/show?id=ac3066568c' target=_blank style='color:#2F92EE;'>#ELCC#</a>, objectTitle=ELCC2015：肺癌研究热点精粹, objectType=article, longId=49805, objectId=ccb0498054a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ccb0498054a, replyNumber=0, likeNumber=105, createdTime=2015-11-26, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ccb0498054a, moduleTitle=ELCC2015：肺癌研究热点精粹, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ccb0498054a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2034132, encodeId=6cb1203413222, content=<a href='/topic/show?id=ac3066568c' target=_blank style='color:#2F92EE;'>#ELCC#</a>, objectTitle=ELCC 2014：非小细胞肺癌患者队列中PD-L1和PD-意大利 Livorno市Toscano肿瘤研究中心肿瘤内科的Armida D’Incec1的表达研究, objectType=article, longId=33185, objectId=63bb33185c5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=63bb33185c5, replyNumber=0, likeNumber=107, createdTime=2014-09-29, rootId=0, userName=chendoc242, userId=8994206, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=63bb33185c5, moduleTitle=ELCC 2014：非小细胞肺癌患者队列中PD-L1和PD-意大利 Livorno市Toscano肿瘤研究中心肿瘤内科的Armida D’Incec1的表达研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=63bb33185c5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2034119, encodeId=7a662034119d5, content=<a href='/topic/show?id=ac3066568c' target=_blank style='color:#2F92EE;'>#ELCC#</a>, objectTitle=ELCC 2014 ：NSCLC研究喜忧参半, objectType=article, longId=33651, objectId=f257336511d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f257336511d, replyNumber=0, likeNumber=69, createdTime=2015-03-08, rootId=0, userName=chendoc242, userId=8994206, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f257336511d, moduleTitle=ELCC 2014 ：NSCLC研究喜忧参半, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f257336511d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2034117, encodeId=440a203411edb, content=<a href='/topic/show?id=ac3066568c' target=_blank style='color:#2F92EE;'>#ELCC#</a>, objectTitle=ELCC 2014：非小细胞肺癌患者队列中PD-L1和PD-意大利 Livorno市Toscano肿瘤研究中心肿瘤内科的Armida D’Incec1的表达研究, objectType=article, longId=33185, objectId=63bb33185c5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=63bb33185c5, replyNumber=0, likeNumber=102, createdTime=2014-08-27, rootId=0, userName=chendoc242, userId=8994206, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=63bb33185c5, moduleTitle=ELCC 2014：非小细胞肺癌患者队列中PD-L1和PD-意大利 Livorno市Toscano肿瘤研究中心肿瘤内科的Armida D’Incec1的表达研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=63bb33185c5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2034133, encodeId=b96f2034133de, content=<a href='/topic/show?id=ac3066568c' target=_blank style='color:#2F92EE;'>#ELCC#</a>, objectTitle=ELCC 2014 ：专家呼吁重视肺癌患者的性功能障碍, objectType=article, longId=33650, objectId=8ffe33650d5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8ffe33650d5, replyNumber=0, likeNumber=85, createdTime=2014-05-04, rootId=0, userName=chendoc242, userId=8994206, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8ffe33650d5, moduleTitle=ELCC 2014 ：专家呼吁重视肺癌患者的性功能障碍, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8ffe33650d5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2034118, encodeId=f6b820341184b, content=<a href='/topic/show?id=ac3066568c' target=_blank style='color:#2F92EE;'>#ELCC#</a>, objectTitle=ELCC 2014 ：专家呼吁重视肺癌患者的性功能障碍, objectType=article, longId=33650, objectId=8ffe33650d5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8ffe33650d5, replyNumber=0, likeNumber=101, createdTime=2015-02-01, rootId=0, userName=chendoc242, userId=8994206, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8ffe33650d5, moduleTitle=ELCC 2014 ：专家呼吁重视肺癌患者的性功能障碍, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8ffe33650d5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2034134, encodeId=e33f20341341e, content=<a href='/topic/show?id=ac3066568c' target=_blank style='color:#2F92EE;'>#ELCC#</a>, objectTitle=ELCC 2014 ：NSCLC研究喜忧参半, objectType=article, longId=33651, objectId=f257336511d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f257336511d, replyNumber=0, likeNumber=74, createdTime=2014-08-09, rootId=0, userName=chendoc242, userId=8994206, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f257336511d, moduleTitle=ELCC 2014 ：NSCLC研究喜忧参半, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f257336511d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2034116, encodeId=a742203411638, content=<a href='/topic/show?id=ac3066568c' target=_blank style='color:#2F92EE;'>#ELCC#</a>, objectTitle=ELCC：多项新技术助改善肺癌预后, objectType=article, longId=5813, objectId=f94158137f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f94158137f, replyNumber=0, likeNumber=72, createdTime=2013-02-22, rootId=0, userName=chendoc242, userId=8994206, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f94158137f, moduleTitle=ELCC：多项新技术助改善肺癌预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f94158137f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2034131, encodeId=3fce203413158, content=<a href='/topic/show?id=ac3066568c' target=_blank style='color:#2F92EE;'>#ELCC#</a>, objectTitle=ELCC：多项新技术助改善肺癌预后, objectType=article, longId=5813, objectId=f94158137f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f94158137f, replyNumber=0, likeNumber=87, createdTime=2012-12-27, rootId=0, userName=chendoc242, userId=8994206, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f94158137f, moduleTitle=ELCC：多项新技术助改善肺癌预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f94158137f)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

ELCC

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#肺癌# #欧洲肺癌大会# #ELCC#

国际会议 | 2024 ELCC：肺癌重点研究摘要速览！

2024-03-16发表于上海

chendoc242 (审核中...)

前往app查看评论内容

#ELCC#

ELCC 2022：创新药临床研究汇总

2022-09-18

chendoc242 (审核中...)

前往app查看评论内容

#ELCC#

ELCC 2022：创新药临床研究汇总

2022-06-06

chendoc242 (审核中...)

前往app查看评论内容

#ELCC#

【ELCC2018】PACIFIC全新数据：1年Durvalumab可推迟多项症状恶化时间

2018-09-13

chendoc242 (审核中...)

前往app查看评论内容

#ELCC#

【ELCC2018】PACIFIC全新数据：1年Durvalumab可推迟多项症状恶化时间

2019-01-25

chendoc242 (审核中...)

前往app查看评论内容

#ELCC#

ELCC 2016：Tagrisso一线治疗EGFR T790M突变NSCLC患者，PFS长达19.3个月

2016-09-05

chendoc242 (审核中...)

前往app查看评论内容

#ELCC#

ELCC 2016：Tagrisso一线治疗EGFR T790M突变NSCLC患者，PFS长达19.3个月

2017-03-02

chendoc242 (审核中...)

前往app查看评论内容

#ELCC#

ELCC2015：肺癌研究热点精粹

2015-05-05

zhaojie88 (审核中...)

前往app查看评论内容

#ELCC#

ELCC2015：肺癌研究热点精粹

2015-11-26

chendoc242 (审核中...)

前往app查看评论内容

#ELCC#

ELCC 2014：非小细胞肺癌患者队列中PD-L1和PD-意大利 Livorno市Toscano肿瘤研究中心肿瘤内科的Armida D’Incec1的表达研究

2014-09-29

chendoc242 (审核中...)

前往app查看评论内容

#ELCC#

ELCC 2014 ：NSCLC研究喜忧参半

2015-03-08

chendoc242 (审核中...)

前往app查看评论内容

#ELCC#

ELCC 2014：非小细胞肺癌患者队列中PD-L1和PD-意大利 Livorno市Toscano肿瘤研究中心肿瘤内科的Armida D’Incec1的表达研究

2014-08-27

chendoc242 (审核中...)

前往app查看评论内容

#ELCC#

ELCC 2014 ：专家呼吁重视肺癌患者的性功能障碍

2014-05-04

chendoc242 (审核中...)

前往app查看评论内容

#ELCC#

ELCC 2014 ：专家呼吁重视肺癌患者的性功能障碍

2015-02-01

chendoc242 (审核中...)

前往app查看评论内容

#ELCC#

ELCC 2014 ：NSCLC研究喜忧参半

2014-08-09

chendoc242 (审核中...)

前往app查看评论内容

#ELCC#

ELCC：多项新技术助改善肺癌预后

2013-02-22

chendoc242 (审核中...)

前往app查看评论内容

#ELCC#

ELCC：多项新技术助改善肺癌预后

2012-12-27

科室
- - 订阅+
  - 更多科室
工具
服务